Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982–2008: overall good news but with rising rates in the oropharynx by Ariyawardana, Anura & Johnson, Newell W.
Ariyawardana and Johnson BMC Cancer 2013, 13:333
http://www.biomedcentral.com/1471-2407/13/333RESEARCH ARTICLE Open AccessTrends of lip, oral cavity and oropharyngeal
cancers in Australia 1982–2008: overall good
news but with rising rates in the oropharynx
Anura Ariyawardana1,2 and Newell W Johnson1*Abstract
Background: Considerable global variation in the incidence of lip, of oral cavity and of pharyngeal cancers exists.
Whilst this reflects regional or population differences in risk, interpretation is uncertain due to heterogeneity of
definitions of sites and of sub-sites within this anatomically diverse region. For Australia, limited data on sub-sites
have been published. This study examines age-standardised incidence trends and demography from 1982 to 2008,
the latest data available.
Methods: Numbers of cases within ICD10:C00-C14 were obtained from the Australian Institute of Health and
Welfare, recorded by sex, age, and sub-site. Raw data were re-analysed to calculate crude, age-specific and
age-standardised incidence using Segi’s world-standard population. Time-trends were analysed using Joinpoint
regression.
Results: Lip, Oral Cavity and Pharyngeal (excluding nasopharynx) cancers, considered together, show a biphasic
trend: in men rising 0.9% pa from 1982 to 1992, and declining 1.6% pa between 1992 and 2008. For females: rises
of 2.0% pa 1982–1997; declines of 2.8% pa 1997–2008. Lip cancer is declining especially significantly. When the
Oropharynx is considered separately, steadily increasing trends of 1.2% pa for men and 0.8% pa for women were
observed from 1982 to 2008.
Conclusions: Although overall rates of lip/oral/oropharyngeal cancer are declining in Australia, these are still high.
This study revealed steady increases in cancers of the oropharynx, beginning in the late 1990s. Continued efforts to
reduce the burden of these cancers are needed, focused on reduction of the traditional risk factors of alcohol and
tobacco, and with special emphasis on the possible role of human papillomavirus and sexual hygiene for cancers of
the oropharynx.
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Cancer is a growing public health problem worldwide.
Overall, 12.4 million new cancer cases and 7.6 million
deaths were reported to have occurred in 2008 [1]. Of
these, estimates of 263,000 new cases of lip and oral cavity
cancers, and 135,000 cases of pharyngeal cancers (exclud-
ing nasopharynx) were reported, representing 2.1% and
1.1% of all new cancers respectively [2]. A large majority
of cancers of the upper aero-digestive tract, excluding the* Correspondence: n.johnson@griffith.edu.au
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distribution, and reproduction in any mediumnasopharynx, are squamous cell carcinomas. Cancers of
the lip, tongue and oral cavity (ICD-10:C00-C06) and of
the oropharynx (ICD-10:C09, C10 and C14) have several
risk factors in common, have similar biology and are often
grouped together [3]. A 20-fold global variation in the in-
cidence of these cancers is apparent in international data-
bases [2,4]. Two-thirds of the burden is within the
developing world, where under-ascertainment of cases is
significant [5]. Importantly, some of the highest rates are
seen in parts of Western and Eastern Europe and the
former Soviet republics [4].
The considerable variation in the pattern of oral and
of oropharyngeal cancer incidence in different parts ofioMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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risk factors. A high incidence of lip cancer is found among
white races exposed to solar radiation. High rates of inci-
dence of cancers of intra-oral sites are reported from com-
munities with high consumption of tobacco, particularly
among users of smokeless tobacco, often in association
with areca nut in the form of betel quid: here, carcinogen-
esis may also be synergised by high consumption of alco-
hol [6-8]. A rising incidence of lip, of oral cavity and of
pharyngeal cancers, taken together (ICD 10: C00-C14),
has been reported in some industrialised countries since
the 1970s: Statistically significant increases of 18% and
30% were observed from 1990 to 1999 in the UK for males
and females respectively [9]. A recent study in Denmark
reported an overall rise in head and neck cancer incidence
between 1978 and 2007, particularly for the oral cavity
(2.2% pa), tonsil (4.8% pa), and oropharynx (3.5% pa) [10].
A significant increase in the incidence of cancer of the
oropharynx (C01, C05.1, C05.2, C09, C10, C12. C13 and
C32) was observed during the period from 1989 to 2006
in the Netherlands, at the rate of 2.5% and 3.0% per year
in males and females respectively [11]. In contrast to this,
declines in lip plus oral cavity plus pharyngeal cancer mor-
tality rates have been reported in several countries e.g.
USA, China, Hong Kong, Italy, Spain, France, Germany
and Australia [12]: with these grouped data, much of the
effect is due to reduction in cancer of the nasopharynx
which is, biologically, a distinctly different disease than
that of most of the upper aerodigestive tract. In addition
to the traditional risk factors, recent data from some west-
ern countries suggest that humanpapillomaviruses (HPV)
are responsible for a rising incidence of oropharyngeal
cancers [13-15]. A recent study in Australia has also
shown increasing trends in potentially HPV-associated
cancers of the oropharynx [16].
Literature on the incidence of oral and of oropharyn-
geal cancer in Australia is scarce, especially relating to
sub-sites within ICD10:C00-C14. In 1971, Tan reported
the countrywide incidence of lip cancer for the period
1959 to 1964. This hospital-based study found a decline
of lip cancer incidence (upper and lower lip combined)
from 6.5/100,000 in 1959 to 4.9/100,000 in 1964 [17].
Macfarlane et al., in 1994, reported patterns of oral and
pharyngeal cancer incidence in New South Wales based
on the population-based cancer registry in that juris-
diction. They found increasing trends of “oral and
pharyngeal cancer” from 6.5/100,000 pa for males and
2.1/100,000 pa for females, respectively, in 1974 to 9.3/
100,000 pa for males and 3.0/100,000 pa for females in
1986. It appears, however, that this trend has not contin-
ued thereafter [18].
A report from the population-based South Australian
Cancer Registry revealed marginally increasing trends of
tongue cancer in males from 0.98/100,000 pa between1977 and 1985, rising to 1.15/100,000 pa between 1994
and 2001: the incidence in females was, however, stable
for the same period at 0.45/100,000 pa [19]. Abreu et al.,
in 2009, described an upward trend in the incidence of
lip cancer in Western Australia with rates of 8.9/100,000
pa and 2.7/100,000 pa for males and females respect-
ively, although these data are based on a small popula-
tion [20]. Another study in Western Australia reported
increasing trends in “oral and pharyngeal” cancer be-
tween 1982 and 1990 peaking at 14.6/100,000 pa for
males and 6.2/100,000 pa for females, with declining
trends thereafter [21].
Interpretation of the available literature is uncertain,
due to heterogeneity of definitions of lip, oral cavity and
of oropharyngeal cancer. To the best of our knowledge,
no literature is available on recent trends of lip, of oral
cavity and of pharyngeal cancers across Australia, based
on strict sub-site analyses. The aim of the present paper
is, therefore, to describe age-standardised incidence,
trends and demography of sub-sites of lip, of oral cavity
and of oropharyngeal cancers (ICD10:C00-C14, exclud-
ing C11, the nasopharynx) from 1982 up to the most re-
cent data available, namely 2008.
Methods
The numbers of cases of head and neck cancers were
obtained for the period 1982 to 2008 from the Australian
Institute of Health and Welfare (AIHW). The AIHW
compiles the Australian Cancer Database, a collation of all
primary malignant neoplasms diagnosed in Australia. This
is compiled from data provided by state and territory can-
cer registries through the Australian Association of Cancer
Registries. Population-based cancer registries receive in-
formation on cancer diagnoses from a variety of sources:
hospitals; pathology laboratories; radiotherapy centres;
and registries of births, deaths and marriages.
The data were segregated by sex, age, and anatomical
site based on the World Health Organisation International
Classification of Diseases for Oncology, 3rd edition (ICD-
O-3) ICD-10 codes. Age was grouped into 5-year bands
0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35-39, 40–
44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79,
80–84 and 85+. Annual mid-year population estimates for
the period by age group and sex were obtained from the
Australian Bureau of Statistics [22].
Cancers in the present analysis are: “Lip and Oral
cavity”, which includes lip (ICD 10; C00); the Oral
Tongue (Anterior two-thirds only; C02); Gum (C03);
Floor of mouth (C04); Hard Palate (C05.0) and other un-
specified parts of mouth (C06). Cancers of the Base of
the tongue (C01), Soft palate (C05.1), Uvula (C05.2),
Tonsil (C09), Oropharynx (C10) and other ill defined
sites of oral cavity and pharynx (C14) were considered
separately as cancers of the “Oropharynx”. Malignant
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pharyngeal sites (Naso- and Hypo-pharynx: C11-13)
were excluded.
Raw data were re-analysed to calculate crude, age-
specific and age-standardised incidence rates. Segi’s
world standard population and the direct method were
used to calculate age-standardised incidence rates [23].
Time trends in age-standardised incidence rates were
analysed using Joinpoint regression modeling [24]. The
Joinpoint programme version 3.5.2 was used [25]. This
analysis generates discrete points that separate different
line segments on a log scale, to describe the trends over
time. The analysis involves 0–4 “Joinpoints” and the
Monte Carlo permutation method to test the level of sig-
nificance of the trends. Annual percentage change (APC)
of each segment, and annual average of APC with corre-
sponding 95% confidence intervals, were estimated. APC
was tested to determine whether the trends are increasing
(positive change) or decreasing (negative change). P values
of <0.05 were considered statistically significant.
Results
A total of 56,226 cases (40,163 in men and 16,063 in
women) of lip, of oral cavity and of oropharyngeal can-
cers were reported during the period from 1982 to 2008.
Table 1 shows the age standardised incidence (ASI) rates
by major sites of the cancers for the beginning (1982)
and the end (2008) of the study period and the results of
the Joinpoint regression analysis for males, females and
both sexes together.
Overall, ASI for Lip, Oral Cavity and Oropharyngeal
cancers combined (C00-06, C09, C10 and C14) for males
declined from 13.67/100,000 in 1982 to 11.01/100,000 in
2008. Female rates were lower, but stable: 4.06/100,000Table 1 Lips, Oral cavity and oropharyngeal cancer incidence
by sex
Site Sex Year 1
ASI (n)
Lip Oral cavity and Oropharynx ICD10 C00-06,C09,C10,
and C14
Male 13.67 (1
Female 4.06 (3
Both sexes 8.34 (1
Lip and Oral cavity ICD10, C00-C06, (Excluding C01) Male 10.84 (9
Female 3.27 (2
Both sexes 6.62 (1
“Oropharynx” ICD10; C01, C05.1, C05.2, C09.07, C091.1,
C09.8, C09.9, C10 and C14
Male 2.83 (2
Female 0.79 (6
Both sexes 1.72 (3
Abbreviations
APC, Annual Percent Change, AAPC, Average Annual Percent Change.
*The Annual Percent Change (APC) is significantly different from zero at alpha = 0.0
*The Average Annual Percent Change (AAPC) is significantly different from zero at ain 1982 and 4.07/100,000 in 2008. When both sexes are
considered together, the ASI for 1982 was 8.34/100,000
and 7.47/100,000 for 2008.
Joinpoint analysis for Lip, Oral Cavity and Oropharyn-
geal cancers combined for men showed an increasing
trend of 0.9% per year from 1982 to 1992, followed by a
decline of 1.6% per year from 1992 to 2008 (Figure 1).
Similar biphasic trends were demonstrated for females,
from a lower base, and with a 5 year time lag: a steady
increase in trend of 2.0% per year from 1982–1997
followed by a sharp decline of 2.8% per year from 1997–
2008 (Figure 2). Consideration of both sexes together for
the same cancers reveals an increasing trend with annual
change of 1.6% from 1982 to 1992 and a declining trend
with 1.4% annual change from 1992 to 2008.
When Lip plus Oral cavity cancers (C00-06) are con-
sidered separately from the pharynx there was a decline
for males from 10.84/100,000 pa in 1982 to 7.04/100,000
in 2008: for females from 3.27/100,000 pa in 1982 to
3.06/100,000 in 2008 and for both sexes from 6.62/
100,000 to 5.01/100,000 in 2008 (Table 1).
Joinpoint analysis for Lip and Oral cavity cancers for
men showed an increasing trend of 0.5% per year from
1982–1994 and a larger declining trend by 3.1% per year
from 1994 to 2008 (Figure 3). There was a steady
increase of 2.3% per year from 1982 to 1996 among
females while a sharp decline of 3.0% per year was dem-
onstrated from 1996 to 2008 (Figure 4). When consider-
ing both sexes together for the same cancers, an
increasing trend with annual change of 0.9% from 1982
to 1995 and declining trend with 2.8% annual change
was shown from 1995 to 2008.
When Oropharyngeal cancers (C01, C05.1, C05.2, C09,
C10 and C14) are considered separately there was anrates for Australian for major sites from 1982–2008
982 Year 2008 Joinpoint analysis (1982–2008)
Trend 1 Trend 2 AAPC
ASI (n) Period APC Period 1999-2008
139) 11.01 (1709) 1982-1992 0.9 1992-2008 −1.6* −1.6*
43) 4.07 (756) 1982-1997 2.0* 1997-2008 −2.8* −2.8*
482) 7.47 (2465) 1982-1992 1.6* 1992-2008 −1.4* −1.4*
04) 7.04 (1107) 1982-1994 0.5 1994-2008 −3.1* −3.1*
77) 3.06 (584) 1982-1996 2.3* 1996-2008 −3.0* −3.0*
181) 5.01 (1691) 1982-1995 0.9* 1995-2008 −2.8* −2.8*
35) 3.97 (602) 1982-2008 1.2* 1.2*
6) 1.01 (172) 1982-2008 0.8* 0.8*
01) 2.46 (774) 1982-2008 1.2* 1.2*
5.
lpha = 0.05.
Figure 1 Trends in the incidence of lip, oral cavity and oropharyngeal cancer (C00-06, C09, C10 and C14), Male 1982–2008.
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100,000 in 2008, for females from 0.79/100,000 in 1982
to 1.01/100,000 in 2008 and for both sexes combined
from 1.72/100,000 in 1982 to 2.46/100,000 in 2008.
Joinpoint analysis for Oropharyngeal cancers for men
showed a steadily increasing trend with annual change
of 1.2% (Figure 5). There was an increase in trend of
0.8% per year from 1982 to 2008 for females (Figure 6).
When both sexes were considered together for the same
cancers of the oropharynx, there was a steadily increas-
ing trend at an annual change of 1.2%.
In this study we have analysed the sub-sites of the Lip,
Oral Cavity and Oropharynx to identify the main con-
tributors to the overall change in trends of major sites.
Table 2 shows the age standardized incidence (ASI) rates
by sub-sites: upper lip (ICD10; C00.0 and C00.3); lower
lip (C00.1 and C00.4); lip unspecified (C00.2, C00.5,Figure 2 Trends in the incidence of lip, oral cavity and oropharyngeaC00.6,C00.8 and C00.9); base of tongue (C01); other and
unspecified parts of tongue (C02); gum (C03.0,C303.1
and C03.9); floor of mouth (C04.0,C04.1,C04.8,C04.9);
palate (C05.0,C05.1,C05.2,C05.8,C05.9); other unspeci-
fied parts of mouth (C06.0,C06.1,C06.2,C06.8, C06.9);
tonsil (C09.0,C09.1,C09.8 and C09.9); oropharynx (C10)
and ill-defined sites of lip, oral cavity and pharynx (C14)
of the cancers for the beginning (1982) and the end
(2008) of the study period and the results of the
Joinpoint regression analysis for males and females.
Cancer of the lower lip was found to be the dominant
anatomical site for both men and women out of all can-
cers considered in the present study, accounting for
35.3% of all Lip, Oral Cavity and Oropharyngeal cancers.
The ASI for males was 4.93/100,000 pa and 3.34/
100,000 pa in 1982 and 2008 respectively. This cancer
showed an increasing trend from 1982 to 1996 with anl cancer (C00-06, C09, C10 and C14), Female 1982–2008.
Figure 3 Trends in the incidence of lip and oral cavity cancer (C00-C06) excluding base of the tongue (C01), Males 1982–2008.
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thereafter. Although overall ASI was small compared to
males, a similar biphasic trend pattern was shown
among females, with 6.1% annual increase and 4.3% an-
nual decrease for the same periods.
Cancer of the upper lip was higher among females
than males. A slight decline was shown amongst males
over the period from 1982 to 2008 with an annual
change of 0.1%. In females there was a sharp increase
from 1982 to 1990 with an annual change of 13.1%
and a decreasing trend thereafter with annual change
of 1.3%.
In males, cancers of the base of tongue have shown an
increasing trend with annual change of 3.2% from 1982–
2008. Although, a similar pattern was shown among fe-
males from 1982 to 2003, a decline with 8.9% annual
change was shown thereafter. Of the other Oropharyn-
geal sites considered in this study, tonsillar cancers haveFigure 4 Trends in the incidence of lip and oral cavity cancer (C00-C0shown overall increasing trends for both males and fe-
males. Most of the other “sub-sites” have shown overall
declining trends.Discussion
Our study provides time trends for cancers of individual
sub-sites according to the ICD 10 classification for those
head and neck neoplasms which have, to a degree, com-
mon risk factors. Joinpoint analysis provides a much
clearer picture of time trends, in different segments of
time, within the overall period concerned. As such we
were able to show that significant changes in trends have
taken place during this period.
There has been an encouraging decline in lip, oral
cavity and pharyngeal cancers overall (ICD10, C00-06,
C09, C10 and C14) in Australia in recent decades. How-
ever, when cancers of the oropharynx are considered6) excluding base of the tongue (C01), Females 1982–2008.
Figure 5 Trends in incidence of Oropharyngeal cancer (C01, C05.1, C05.2, C09.0, C09.1, C09.8, C09.9, C10 and C14,). Males 1982–2008.
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among men, from 1982 to 2008.
We have shown biphasic trends for Lip, Oral Cavity
and for Oropharyngeal cancers combined for both men
and women. An increasing trend of 0.9% p.a. from 1982
to 1992 and a decline of 1.6% p.a. from 1992 to 2008
were observed in males. Similar biphasic trends were
demonstrated among females with a steady increase of
2.0% pa from 1982–1997 and a sharp decline of 2.8% pa
thereafter. In a study covering the State of New South
Wales, Macfarlane et al., in 1994, reported a similar
pattern:. They found increasing incidence of “oral and
pharyngeal” cancer from 6.5/100,000 pa to 9.3/100,000
pa among males, and from 2.1/100,000 pa to 3.0/100,000
pa among females, from 1974 to 1986: However, this
trend declined thereafter [18]. Another epidemiological
study on “lip and oral cavity” (which unfortunatelyFigure 6 Trends in the incidence of Oropharyngeal cancer (C01, C05.1
Females 1982–2008.included cancers of the major salivary glands), based on
data from the Cancer Registry of Western Australia,
reported increasing trends in “oral and pharyngeal can-
cer” from 1982–1990 at the rate of 14.6/100,000 p.a. for
males and 6.2/100,000 p.a. for females and observed de-
clining trends thereafter [21].
Since the second half of the last century reports from
many parts of the world on the incidence of “oral can-
cer” have described declining, stable or increasing rates
in different regions or countries [4,9-12,15,26]. Because
of the impossibility of linking cause and effect directly,
there is no unambiguous explanation for the causes of
these trends. However, the most conceivable explana-
tions are life-style changes, particularly changes in smok-
ing rates [27] and spread of HPV infections [10-12].
Overall per capita tobacco consumption in Australia
has declined steadily since the latter part of the last, C05.2, C09.0, C09.1, C09.8, C09.9, C10 and C14,).
Table 2 Lips, Oral cavity and oropharyngeal cancer incidence rates for Australia according to sub-sites from 1982–2008
by sex
Site Sex ASI Joinpoint analysis (1982-2008)
Year
1982
Year
2008
Trend 1 Trend 2 AAPC
Period APC Period APC 1999-2008 2004-2008
Upper lip ICD10; C00.0 and C00.3 Male 0.26 0.19 1982-2008 −0.1 −0.1 −0.1
Female 0.19 0.26 1982-1990 13.1* 1990-2008 −1.3 −1.3 −1.3
Lower lip ICD10; C00.1 and C00.4 Male 4.93 3.34 1982-1996 1.5* 1996-2008 −4.2* −4.2* −4.2*
Female 0.68 0.9 1982-1996 6.1* 1996-2008 −4.3* −4.3* −4.3*
Lip unspecified** ICD10;C00.2, C00.5,C00.6,
C00.8 and C00.9
Male 1.58 0.25 1982-1996 −2.2 1996-2008 −10.5* −10.5* −10.5*
Female 0.13 0.09 1982-1989 12.9* 1989-2008 −6.2* −6.2* −6.2*
Base of tongue ICD10;C01 Male 0.62 1.03 1982-2008 3.2* 3.2* 3.2*
Female 0.12 0.22 1982-2003 4.2* 2003-2008 −8.9 −3.3 −8.9
Other and unspecified parts of tongue
ICD10;C02
Male 1.81 1.61 1982-2008 −1.0* −1.0* −1.0*
Female 0.94 0.79 1982-2008 −0.1* −0.1* −0.1*
Gum ICD10;C03.0,C03.1 and C03.9 Male 0.22 0.22 1982-2008 0.4 0.4 0.4
Female 0.21 0.25 1982-2008 1.0* 1.0* 1.0*
Floor of Mouth ICD10;C04.0,C04.1,C04.8, C04.9 Male 1.42 0.72 1982-2008 −2.6* −2.6* −2.6*
Female 0.4 0.25 1982-2008 −2.1* −2.1* −2.1*
Palate ICD10;C05.0,C05.1,C05.2, C05.8, C05.9 Male 0.5 0.4 1982-2008 −1.9* −1.9* −1.9*
Female 0.25 0.29 1982-2008 −0.4 −0.4 −0.4
Other unspecified parts of mouth ICD10;C06.0,
C06.1,C06.2, C06.8, C06.9
Male 0.39 0.53 1982-2008 0.01 0.0 0.0
Female 0.34 0.33 1982-2008 0.01 0.0 0.0
Tonsil ICD10; C09.0,C09.1,C09.8 and C09.9 Male 1.1 1.9 1982-1995 −0.3 1995-2008 4.3* 4.3* 4.3*
Female 0.36 0.49 1982-2008 1.1* 1.1* 1.1*
Oropharynx ICD10; C10 Male 0.6 0.47 1982-2008 −2.2* −2.2* −2.2*
Female 0.15 0.11 1982-2008 −1.7* −1.7* −1.7*
Ill defined sites of lip, oral cavity and pharynx
ICD10;C14
Male 0.29 0.35 1982-2008 1.5* −1.5* −1.5*
Female 0.09 0.05 1982-2008 −1.0 −1.0 −1.0
Abbreviations
APC, Annual Percent Change AAPC, Average Annual Percent Change.
*The Annual Percent Change (APC) is significantly different from zero at alpha = 0.05.
*The Average Annual Percent Change (AAPC) is significantly different from zero at alpha = 0.05.
**Include commissure.
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bacco use declined from 58% in 1964 to 18% in 2007. In
contrast, among females the prevalence of tobacco
smoking increased from 28% in 1964 to a peak of 31% in
1980, with a subsequent decline to 15.2% in 2007 [28].
The National Drug Strategy Household Survey 2010
revealed a substantial – almost 40% - reduction in the
prevalence of daily smokers in Australia for people aged
14 years or older from 24.3% in 1991 to 15.1% in 2010,
[29]. However, increased smoking among females from
1964 to 1980 may have contributed to the statistically
significant increase of lip, oral cavity and pharyngeal
cancers observed in the present analyses during the
1982–1992 period.The synergistic effect of alcohol consumption and
smoking has been well established [30]. Overall per
capita alcohol consumption in Australia in 1960 was es-
timated at 9.4 L pa. This gradually increased to 13.0 L in
1980 and slowly declined to 10.1 L in 2009 [28]. In 2010,
1 in 5 people in Australia at or over the age of 14 years
consumed alcohol at harmful levels [29].
A recent report from France indicated a considerable
decrease of upper aero-digestive tract cancers in men,
while the same were increased in women over the 25
year period from 1980 to 2005, especially oropharyngeal,
palatal and hypopharyngeal cancers: world-standardised
incidence rates of lip, oral cavity and pharynx cancers
combined declined by 42.9% in men while females
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of smoking among men in the general population and
slightly increasing tobacco smoking in women were sug-
gested as accounting for these changes [31]. Significant
declines in the incidence of oral cavity and pharyngeal
cancers for both men and women in all races in the
USA have been observed over the period from 1977 to
2007, reflecting the steady decline in smoking and alco-
hol consumption in that nation [32]. Another recent
study from the USA reported decreasing trends of oral
plus pharyngeal cancers for women with APC of −1.0
from 1992 to 2008. In contrast to women, although men
showed a decreasing trend with APC of −1.4 from 1982
to 2006, this turned to a rise of 3% pa from 2006 [15].
Unfortunately it is not possible to separate sub-sites in
these data.
Lip cancer has been the dominant site in the oral and
oropharyngeal region in Australia, contributing over
36% of cases, of which 90% are cancers of the lower lip.
These are more common in males with ASI 4.93/
100,000 and 3.34/100,000 in 1982 and 2008 respectively.
Although this cancer has shown an increasing trend
from 1982 to 1996 with an annual change of 1.5%, a
decline of 4.2% per year was observed thereafter. Com-
pared to males the overall ASI was small, but a com-
parable biphasic trend pattern was observed among
females, with 6.1% annual increase and 4.3% annual de-
crease for the same periods.
Contrary to this Tan (1971), in a countrywide hospital
based survey, reported a declining trend in lip cancer
(upper and lower lip combined) from 6.5/100,000 in
1959 to 4.9/100,000 in 1964 [17]. He found that cancers
of the lower lip were 9.9 times more common among
males compared to females, whereas the present study
revealed a male to female ratio of only 3:1. However,
these are quite old data and, in a hospital-based study,
under-reporting is likely.
In a state-based study on lip cancer in Western
Australia, Abreu et al. (2009) reported an upward trend
with 8.9/100,000 and 2.7/100,000 pa for males and fe-
males respectively from 1982 to 2006 [20]. These figures
are high compared to the national data reported here,
variations in incidence in different states in Australia
probably being attributable to differences in the rural/
urban population mix and in exposure to risk factors.
Lip cancer is much more common in those who live or
work outdoors, with direct exposure to sunlight [33,34].
High incidence has long been associated with prolonged
exposure to solar radiation, especially in people with fair
complexion [33-37]. The lower lip receives considerably
more direct sunlight than the upper lip [34]. In contrast,
the comparatively low incidence of lower lip cancer
among females could be attributed to the protective ef-
fect of cosmetics and lower outdoor exposures [38].The present study revealed that cancer of the upper lip
was higher among females than males. Moreover, there
was a sharp increase in incidence from 1982 to 1990, an
annual change of 13.1%, which started declining thereafter
with annual change of 1.3%. In contrast, a slight decline in
cancer of the upper lip was observed amongst males over
the whole period from 1982 to 2008, with an annual
change of 0.1%. As with the present study, significant fe-
male predilection for cancers of the upper lip was reported
from Western Australia [20]. An almost equal sex distri-
bution of upper lip cancers was reported in another
Australia-wide hospital-based study in 1971 [17]. Al-
though no unambiguous explanation for a higher inci-
dence of upper lip cancers among females can be given,
differences in exposure factors, particularly increasing
prevalence of tobacco smoking among females from the
early 1960’s until 1980, may have contributed [28].
In contrast to “lip and oral cavity” cancers, when
“oropharyngeal” cancers are considered separately, we
have observed increasing trends, throughout the period
analysed here. Oropharyngeal cancer has been reported to
be increasing significantly and quickly in several countries,
particularly in the developed world, and is widely regarded
as associated with infection with humanpapillomaviruses
of known high oncogenic potential – especially HPV-16
and −18 [10,13,14,39-41]. A recent report from Australia
described a significant increase in potentially HPV-
associated head and neck cancers in both males and
females between 1982 and 2005, with an annual per-
centage increase of 1.04% and 1.42% for females and
males respectively [16]. Our findings are comparable
with this, but changes in life-style risk factors, especially
smoking and heavy alcohol consumption, and their syn-
ergism, will have confounding effects in understanding
the causes of cancers in these sites. Varying degrees of
exposure may partly explain differences between males
and females.
Although overall rates of lip, oral cavity and pharyngeal
cancer are currently declining in Australia, these are
still high in comparison with many other countries.
Efforts to reduce the burden of these cancers remain
vital. Further reductions in exposure to lifestyle risk
factors: ultraviolet light; all forms of tobacco; excessive
alcohol use/abuse; and the consumption of diets rich
in antioxidants and minerals, need to be promoted.
Sexual hygiene needs to be promoted to reduce the
carriage of HPVs in the upper aero-digestive tract: it
will be interesting to examine the extent to which current
vaccination programs against oncogenic HPVs, at present
focused on young women for the prevention of cancer of
the uterine cervix, lead to reductions in oropharyngeal
cancer in the long term [42,43].
Limitations of our study include the small number of
cases in certain sub-sites and subgroups, an inevitability
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during the period under study) spread over a vast geo-
graphical area, and that we have not been able to explore
differences by ethnic group as we were not permitted ac-
cess to this information for ethical reasons.
Conclusions
This study has demonstrated encouraging reductions in
the combined incidence of Lip, Oral cavity and Oropha-
ryngeal Cancers over the study period. This is consistent
with the steady decline in known life style risk factors
such as tobacco smoking and alcohol drinking. Although
this is overall good news, work is needed to reduce the
incidence further, since the rates are still high compared
to several other countries. While some cancers have
shown a particularly steep decline, notably cancers of
the lower lip, there has been a disturbing increase of
cancers of the tonsil and base of tongue, consistent with
global trends, and likely to be related to increasing HPV
infections of the oropharynx. Revised public health mes-
sages and continued surveillance is required to negate
these rising trends. Moreover, it is imperative to under-
take studies to identify particularly vulnerable groups in
Australian society.
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